Related Experiment Video
Updated: Aug 14, 2026
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Absence of mutations in the coding sequence of the potential tumor suppressor 3pK in metastatic melanoma
Roland Houben1, Jürgen C Becker, Ulf R Rapp
1Institut für Medizinische Strahlenkunde und Zellforschung (MSZ), Universität Würzburg, Versbacher Str. 5, D-97078 Würzburg, Germany. houben_r@klinik.uni-wuerzburg.de
Background:
Activation of Ras or Raf contributes to tumorigenesis of melanoma. However, constitutive Raf activation is also a characteristic of the majority of benign melanocytic nevi and high intensity signaling of either Ras or Raf was found to induce growth inhibition and senescence rather than transformation. Since the chromosome 3p kinase (3pK)) is a target of the Ras/Raf/Mek/Erk signaling pathway which antagonizes the function of the oncogene and anti-differentiation factor Bmi-1, 3pK may function as a tumor suppressor in tumors with constitutive Ras/Raf activation. Consequently, we tested whether inactivating 3pK mutations are present in melanoma.
Methods:
30 metastatic melanoma samples, which were positive for activating mutations of either BRaf or NRas, were analyzed for possible mutations in the 3pk gene. The 10 coding exons and their flanking intron sequences were amplified by PCR and direct sequencing of the PCR products was performed.
Results:
This analysis revealed that besides the presence of some single nucleotide polymorphisms in the 3pk gene, we could not detect any possible loss of function mutation in any of these 30 metastatic melanoma samples selected for the presence of activating mutations within the Ras/Raf/Mek/Erk signaling pathway.
Conclusion:
Hence, in melanoma with constitutively active Ras/Raf inactivating mutations within the 3pk gene do not contribute to the oncogenic phenotype of this highly malignant tumor.
Insights
Inactivating mutations in the 3p kinase (3pK) gene do not drive melanoma development, even when Ras/Raf signaling is highly active. This suggests 3pK is not a tumor suppressor in this context.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Melanoma tumorigenesis is linked to Ras/Raf pathway activation.
- High Ras/Raf signaling can induce senescence, not transformation.
- 3p kinase (3pK) targets the Ras/Raf/Mek/Erk pathway and antagonizes Bmi-1, suggesting a tumor suppressor role.
Purpose of the Study:
- To investigate the presence of inactivating 3pK mutations in melanoma.
- To determine if 3pK mutations contribute to the oncogenic phenotype in Ras/Raf-activated melanomas.
Main Methods:
- Analysis of 30 metastatic melanoma samples with known BRaf or NRas mutations.
- PCR amplification and direct sequencing of the 10 coding exons and flanking introns of the 3pk gene.
Main Results:
- Single nucleotide polymorphisms were found in the 3pk gene.
- No loss-of-function mutations in the 3pk gene were detected in the selected melanoma samples.
Conclusions:
- Inactivating mutations in the 3pk gene are not a significant factor in the oncogenesis of melanomas with constitutive Ras/Raf activation.
- 3pK does not appear to function as a tumor suppressor in this specific melanoma context.
Related Concept Videos
02:23Abnormal Proliferation
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...